Assessing causal relationships in genomics: From Bradford-Hill criteria to complex gene-environment interactions and directed acyclic graphs

Emerging Themes in Epidemiology

Volumn 8, Issue , 2011, Pages

  Geneletti, Sara ^a   Gallo, Valentina ^b,c   Porta, Miquel ^d   Khoury, Muin J ^e   Vineis, Paolo ^b,f  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^f Human Genetics Foundation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DJ 1 PROTEIN; PARAQUAT; PESTICIDE;

ARTICLE; CLINICAL GENETICS; CONCEPTUAL FRAMEWORK; DIRECTED ACCYLIC GRAPH; DISEASE ASSOCIATION; DROSOPHILA; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HEALTH STATUS; HUMAN; NEUROPATHOLOGY; NONHUMAN; OBSERVATIONAL STUDY; PARKINSON DISEASE; STATISTICAL MODEL;

EID: 79958040723     PISSN: None     EISSN: 17427622     Source Type: Journal    
DOI: 10.1186/1742-7622-8-5     Document Type: Article

References (76)

1. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. DA Lawlor RM Harbord JA Sterne N Timpson SG Davey, Stat Med 2008 27 1133 1163 10.1002/sim.3034 17886233 (Pubitemid 351395448)
2. Assessment of cumulative evidence on genetic associations: interim guidelines. JP Ioannidis P Boffetta J Little TR O'Brien AG Uitterlinden P Vineis DJ Balding A Chokkalingam SM Dolan WD Flanders JP Higgins MI McCarthy DH McDermott GP Page TR Rebbeck D Seminara MJ Khoury, Int J Epidemiol 2008 37 120 132 17898028 (Pubitemid 351228620)
3. A Dictionary of Epidemiology. M Porta ed, New York: Oxford University Press 5 2008 p. 34-37, 65-66, 82-84, 100-103, 116, 129-130, 152-154, 237-238
4. Evolution of Epidemiologic Ideas. Annotated Readings on Concepts and Methods. S Greenland ed, Chestnut Hill, MA: Epidemiology Resources 1987
5. A History of Epidemiologic Methods and Concepts. A Morabia, Basel: Birkhäuser / Springer 2004
6. Clinical Epidemiology -the Essentials. RH Fletcher SW Fletcher, Philadelphia: Lippincott Williams & Wilkins 4 2005
7. Clinical epidemiology. How to do clinical practice research. RB Haynes DL Sackett GH Guyatt P Tugwell, Philadelphia: Lippincott, Williams & Wilkins 3 2006
8. The environment and disease: association or causation? AB Hill, Proc R Soc Med 1965 58 295 300 14283879
9. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. P Vineis M Manuguerra FK Kavvoura S Guarrera A Allione F Rosa A Di Gregorio S Polidoro F Saletta JP Ioannidis G Matullo, J Natl Cancer Inst 2009 101 24 36 19116388
10. Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. DM Maraganore M de Andrade A Elbaz MJ Farrer JP Ioannidis R Krüger WA Rocca NK Schneider TG Lesnick SJ Lincoln MM Hulihan JO Aasly T Ashizawa MC Chartier-Harlin H Checkoway C Ferrarese G Hadjigeorgiou N Hattori H Kawakami JC Lambert T Lynch GD Mellick S Papapetropoulos A Parsian A Quattrone O Riess EK Tan C Van Broeckhoven, JAMA 2006 296 661 670 10.1001/jama.296.6.661 16896109 (Pubitemid 44200637)
11. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. JP Ioannidis TA Trikalinos MJ Khoury, Am J Epidemiol 2006 164 609 614 10.1093/aje/kwj259 16893921 (Pubitemid 44453487)
12. How many genes underlie the occurrence of common complex diseases in the population? Q Yang MJ Khoury J Friedman J Little WD Flanders, Int J Epidemiol 2005 34 1129 1137 10.1093/ije/dyi130 16043441 (Pubitemid 41535561)
13. Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials. JP Ioannidis TA Trikalinos, J Clin Epidemiol 2005 58 543 549 10.1016/j.jclinepi. 2004.10.019 15878467 (Pubitemid 40692719)
14. Hypothesis: a unifying mechanism for nutrition and chemicals as lifelong modulators of DNA hypomethylation. DH Lee DR Jacobs Jr M Porta, Environ Health Perspect 2009 117 1799 1802 20049195
15. Finding genes that underlie complex traits. AM Glazier JH Nadeau TJ Aitman, Science 2002 298 2345 2349 10.1126/science.1076641 12493905 (Pubitemid 36014199)
16. Environmental epigenomics and disease susceptibility. RL Jirtle MK Skinner, Nat Rev Genet 2007 8 253 62 10.1038/nrg2045 17363974 (Pubitemid 46439287)
17. Phenotypic plasticity and the epigenetics of human disease. AP Feinberg, Nature 2007 447 433 440 10.1038/nature05919 17522677 (Pubitemid 46816750)
18. Environmental exposures and gene regulation in disease etiology. TM Edwards JP Myers, Environ Health Perspect 2007 115 1264 1270 10.1289/ehp.9951 17805414 (Pubitemid 47484765)
19. Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression. F Bellivier C Henry A Szöke F Schürhoff M Nosten-Bertrand J Feingold JM Launay M Leboyer JL Laplanche, Neurosci Lett 1998 255 143 146 10.1016/S0304-3940(98)00677-6 9832193 (Pubitemid 28506022)
20. 5,10-Methylenetetrahydrofolate reductase polymorphisms and pharmacogenetics: a new role of single nucleotide polymorphisms in the folate metabolic pathway in human health and disease. YI Kim, Nutr Rev 2005 63 398 407 10.1111/j.1753-4887.2005.tb00377.x 16370225
21. Double-strand break DNA repair genotype predictive of later mortality and cancer incidence in a cohort of non-smokers. D Neasham V Gallo S Guarrera A Dunning K Overvad A Tjonneland F Clavel-Chapelon JP Linseisen C Malaveille P Ferrari H Boeing V Benetou A Trichopoulou D Palli P Crosignani R Tumino S Panico HB Bueno de Mesquita PH Peeters CH van Gib E Lund CA Gonzalez C Martinez M Dorronsoro A Barricarte C Navarro JR Quiros G Berglund B Jarvholm KT Khaw,, et al. DNA Repair 2008
22. NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population. PM Marcus P Vineis N Rothman, Pharmacogenetics 2000 10 115 122 10.1097/00008571-200003000-00003 10761999 (Pubitemid 30193073)
23. Interplay between heterocyclic amines in cooked meat and metabolic phenotype in the etiology of colon cancer. P Vineis A McMichael, Cancer Causes Control 1996 7 479 486 10.1007/BF00052675 8813437 (Pubitemid 26228338)
24. Aromatic amines and cancer. P Vineis R Pirastu, Cancer Causes Control 1997 8 346 355 10.1023/A:1018453104303 9498898 (Pubitemid 27297802)
25. A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer. HM Ochs-Balcom G Wiesner RC Elston, Am J Epidemiol 2007 166 246 254 10.1093/aje/kwm066 17535831 (Pubitemid 47216806)
26. N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients. J Borlak SM Reamon-Buettner, BMC Med Genet 2006 7 58 10.1186/1471-2350-7-58 16827944
27. Postmenopausal estrogen use and heart disease. N Engl J Med 1986 315 131 136 3724801
28. Evidence of gene gene interactions in lung carcinogenesis in a large pooled analysis. P Vineis S Anttila S Benhamou M Spinola A Hirvonen C Kiyohara SJ Garte R Puntoni A Rannug RC Strange E Taioli, Carcinogenesis 2007 28 1902 1905 10.1093/carcin/bgm039 17307802 (Pubitemid 47500601)
29. Mice, the motor system, and human motor neuron pathology. SJ Nicholson AS Witherden M Hafezparast JE Martin EM Fisher, Mamm Genome 2000 11 1041 1052 10.1007/s003350010205 11130970
30. How is causal inference practised in the biological sciences? M Porta C Álvarez-Dardet, J Epidemiol Community Healt 2000 54 559 560 10.1136/jech.54.7.559
31. Causal diagrams for epidemiologic research. S Greenland J Pearl JM Robins, Epidemiology 1999 10 37 48 10.1097/00001648-199901000-00008 9888278 (Pubitemid 29014427)
32. Instruments for causal inference: an epidemiologist's dream? MA Hernán JM Robins, Epidemiolog 2006 17 360 372 10.1097/01.ede.0000222409. 00878.37 (Pubitemid 44305508)
33. Causal Inference. MA Hernán JM Robins, New York: Chapman & Hall/CRC 2010
34. Causality: Models, Reasoning, and Inference. J Pearl, Cambridge, U.K.: Cambridge University Press 2009
35. Conditional independence in statistical theory. With discussion. AP Dawid, J Roy Statist Soc B 1979 41 1 31
36. Nature's capacities and their measurement. N Cartwright, 1989
37. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? SG Davey S Ebrahim, Int J Epidemiol 2003 32 1 22 10.1093/ije/dyg070 12689998 (Pubitemid 36503465)
38. Influence diagrams for causal modelling and inference. AP Dawid, Intern Statist Rev 2002 70 161 189
39. Mendelian randomization as an instrumental variable approach to causal inference. V Didelez N Sheehan, Stat Methods Med Res 2007 16 309 330 10.1177/0962280206077743 17715159 (Pubitemid 47215256)
40. Alcohol intake and blood pressure: a systematic review implementing a Mendelian randomization approach. L Chen SG Davey RM Harbord SJ Lewis, PLoS Med 2008 5 52 10.1371/journal.pmed.0050052 18318597
41. Causal inference without counterfactuals. AP Dawid, J Am Statist Ass 2000 95 407 448 10.2307/2669377
42. Mendelian randomisation: why epidemiology needs a formal language for causality. V Didelez N Sheenan, Causality and probability in the sciences College Publications London, London 2007 ed ?
43. Identifying direct and indirect effects in a non-counterfactual framework. S Geneletti, J Roy Stat Soc B 2007 69 199 215 10.1111/j.1467-9868. 2007.00584.x
44. Graphical models. S Lauritzen, Oxford 1996
45. Neuroepidemiology. LM Nelson CM Tanner SK Van Den Eeden V McGuire, Oxford Oxford University Press 2004
46. Scientists probe role of genes, environment in Parkinson disease. BM Kuehn, JAMA 2006 295 1883 1885 10.1001/jama.295.16.1883 16639038
47. Genetics of Parkinson disease: paradigm shifts and future prospects. MJ Farrer, Nat Rev Genet 2006 7 306 318 16543934
48. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. CM Clements RS McNally BJ Conti TW Mak JP Ting, Proc Natl Acad Sci USA 2006 103 15091 15096 10.1073/pnas.0607260103 17015834 (Pubitemid 44583169)
49. Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. M Meulener AJ Whitworth CE Armstrong-Gold P Rizzu P Heutink PD Wes LJ Pallanck NM Bonini, Curr Biol 2005 15 1572 1577 10.1016/j.cub.2005.07.064 16139213 (Pubitemid 41219597)
50. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. CM van Duijn MC Dekker V Bonifati RJ Galjaard JJ Houwing-Duistermaat PJ Snijders L Testers GJ Breedveld M Horstink LA Sandkuijl JC van Swieten BA Oostra P Heutink, Am J Hum Genet 2001 69 629 634 10.1086/322996 11462174 (Pubitemid 32777700)
51. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. V Bonifati P Rizzu MJ van Baren O Schaap GJ Breedveld E Krieger MC Dekker F Squitieri P Ibanez M Joosse JW van Dongen N Vanacore JC van Swieten A Brice G Meco CM van Duijn BA Oostra P Heutink, Science 2003 299 256 259 10.1126/science.1077209 12446870 (Pubitemid 36131051)
52. Molecular pathways to neurodegeneration. E Bossy-Wetzel R Schwarzenbacher SA Lipton, Nat Med 2004 10 Suppl 2 S9 15272266
53. Pesticides and Parkinson's disease-is there a link? TP Brown PC Rumsby AC Capleton L Rushton LS Levy, Environ Health Perspect 2006 114 156 164 10.1289/ehp.8095 16451848 (Pubitemid 43193633)
54. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. R Betarbet TB Sherer G MacKenzie M Garcia-Osuna AV Panov JT Greenamyre, Nat Neurosci 2000 3 1301 1306 10.1038/81834 11100151
55. An epidemiologic approach to ecogenetics. MJ Khoury MJ Adams Jr WD Flanders, Am J Hum Genet 1988 42 89 95 3337114 (Pubitemid 18081285)
56. An epidemiologic approach to gene-environment interaction. R Ottman, Genet Epidemiol 1990 7 177 185 10.1002/gepi.1370070302 2369997 (Pubitemid 20334089)
57. Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. G Davey Smith DA Lawlor R Harbord N Timpson I Day S Ebrahim, PLoS Med 2007 4 352 10.1371/journal.pmed.0040352 18076282
58. Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. A Alcaro R Huber J Panksepp, Brain Res Rev 2007 56 283 321 10.1016/j.brainresrev.2007.07.014 17905440 (Pubitemid 350176598)
59. Directed acyclic graphs, sufficient causes, and the properties of conditioning on a common effect. TJ VanderWeele JM Robins, Am J Epidemiol 2007 166 1096 1104 10.1093/aje/kwm179 17702973 (Pubitemid 47574683)
60. Smoking, nicotine and Parkinson's disease. M Quik, Trends Neurosci 2004 27 561 568 10.1016/j.tins.2004.06.008 15331239 (Pubitemid 39149826)
61. The identification of synergism in the sufficient-component-cause framework. TJ VanderWeele JM Robins, Epidemiology 2007 18 329 339 10.1097/01.ede.0000260218.66432.88 17435441 (Pubitemid 46624942)
62. DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism. V Bonifati P Rizzu F Squitieri E Krieger N Vanacore JC van Swieten A Brice CM van Duijn B Oostra G Meco P Heutink, Neurol Sci 2003 24 159 160 10.1007/s10072-003-0108-0 14598065 (Pubitemid 37304291)
63. Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. S Hague E Rogaeva D Hernandez C Gulick A Singleton M Hanson J Johnson R Weiser M Gallardo B Ravina K Gwinn-Hardy A Crawley PH St George-Hyslop AE Lang P Heutink V Bonifati J Hardy A Singleton, Ann Neurol 2003 54 271 274 10.1002/ana.10663 12891685 (Pubitemid 36909631)
64. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. HH Liou MC Tsai CJ Chen JS Jeng YC Chang SY Chen RC Chen, Neurology 1997 48 1583 1588 9191770
65. Plantation work and risk of Parkinson disease in a population-based longitudinal study. H Petrovitch GW Ross RD Abbott WT Sanderson DS Sharp CM Tanner KH Masaki PL Blanchette JS Popper D Foley L Launer LR White, Arch Neurol 2002 59 1787 1792 10.1001/archneur.59.11.1787 12433267 (Pubitemid 35340490)
66. Parkinson's disease: a case-control study of occupational and environmental risk factors. C Hertzman M Wiens D Bowering B Snow D Calne, Am J Ind Med 1990 17 349 355 10.1002/ajim.4700170307 2305814 (Pubitemid 20155397)
67. Parkinson's disease and exposure to agricultural work and pesticide chemicals. KM Semchuk EJ Love RG Lee, Neurology 1992 42 1328 1335 1620342
68. Pesticides and risk of Parkinson disease: a population-based case-control study. JA Firestone T Smith-Weller G Franklin P Swanson WT Longstreth Jr H Checkoway, Arch Neurol 2005 62 91 95 10.1001/archneur.62.1.91 15642854 (Pubitemid 40105040)
69. Neurotoxic effects induced by intracerebral and systemic injection of paraquat in rats. MT Corasaniti G Bagetta P Rodino S Gratteri G Nistico, Hum Exp Toxicol 1992 11 535 539 10.1177/096032719201100616 1361145 (Pubitemid 23023520)
70. Plasma organochlorine levels and risk of non-Hodgkin lymphoma in a cohort of men. KA Bertrand D Spiegelman JC Aster LM Altshul SA Korrick SJ Rodig SM Zhang T Kurth F Laden, Epidemiology 2010 21 172 180 10.1097/EDE.0b013e3181cb610b 20087190
71. Influence of tumor stage, symptoms and time of blood draw on serum concentrations of organochlorine compounds in exocrine pancreatic cancer. M Porta J Pumarega T Lápez M Jariod E Marco JO Grimalt, Cancer Causes Contro 2009 20 1893 1906 10.1007/s10552-009-9383-2
72. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. AL McCormack M Thiruchelvam AB Manning-Bog C Thiffault JW Langston DA Cory-Slechta DA Di Monte, Neurobiol Dis 2002 10 119 127 10.1006/nbdi.2002.0507 12127150 (Pubitemid 34775465)
73. Intermediacy and gene-environment interaction: the example of CHRNA5-A3 region, smoking, nicotine dependence, and lung cancer. S Wacholder N Chatterjee N Caporaso, J Natl Cancer Inst 2008 100 1488 1491 10.1093/jnci/djn380 18957674
74. Can DAGs clarify effect modification? CR Weinberg, Epidemiology 2007 18 569 572 10.1097/EDE.0b013e318126c11d 17700243 (Pubitemid 47263029)
75. Causal thinking in the health sciences. M Susser, New York: Oxford University Press 1973
76. Four types of effect modification: a classification based on directed acyclic graphs. TJ VanderWeele JM Robins, Epidemiology 2007 18 561 568 10.1097/EDE.0b013e318127181b 17700242 (Pubitemid 47263028)